Correlation Between Pasithea Therapeutics and TNF Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and TNF Pharmaceuticals,, you can compare the effects of market volatilities on Pasithea Therapeutics and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and TNF Pharmaceuticals,.

Diversification Opportunities for Pasithea Therapeutics and TNF Pharmaceuticals,

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pasithea and TNF is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and TNF Pharmaceuticals,

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 3.39 times more return on investment than TNF Pharmaceuticals,. However, Pasithea Therapeutics is 3.39 times more volatile than TNF Pharmaceuticals,. It trades about 0.15 of its potential returns per unit of risk. TNF Pharmaceuticals, is currently generating about 0.0 per unit of risk. If you would invest  2.03  in Pasithea Therapeutics Corp on September 25, 2024 and sell it today you would earn a total of  0.27  from holding Pasithea Therapeutics Corp or generate 13.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy42.86%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  TNF Pharmaceuticals,

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly unsteady basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
TNF Pharmaceuticals, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TNF Pharmaceuticals, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, TNF Pharmaceuticals, is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pasithea Therapeutics and TNF Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and TNF Pharmaceuticals,

The main advantage of trading using opposite Pasithea Therapeutics and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.
The idea behind Pasithea Therapeutics Corp and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities